Targeting interleukin-21 in rheumatoid arthritis (Q37789657)

23 August 2017

title

Targeting interleukin-21 in rheumatoid arthritis (English)

1 reference

23 August 2017

0 references

1 reference

2

Wei Hu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:20848219

15 July 2024

author name string

Feng-Lai Yuan

1

1 reference

23 August 2017

Wei-Guo Lu

3

1 reference

23 August 2017

Xia Li

4

1 reference

23 August 2017

Jian-Ping Li

5

1 reference

23 August 2017

Rui-Sheng Xu

6

1 reference

23 August 2017

Cheng-Wan Li

7

1 reference

23 August 2017

Fei-Hu Chen

8

1 reference

23 August 2017

Cheng Jin

9

1 reference

23 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20848219

15 July 2024

publication date

17 September 2010

1 reference

full work available at URL

23 August 2017

http://link.springer.com/content/pdf/10.1007/s11033-010-0285-x.pdf

1 reference

https://api.crossref.org/works/10.1007/S11033-010-0285-X

http://link.springer.com/article/10.1007/s11033-010-0285-x/fulltext.html

15 July 2024

1 reference

https://api.crossref.org/works/10.1007/S11033-010-0285-X

http://link.springer.com/content/pdf/10.1007/s11033-010-0285-x

15 July 2024

1 reference

DOI

https://api.crossref.org/works/10.1007/S11033-010-0285-X

Molecular Biology Reports

15 July 2024

published in

1 reference

23 August 2017

volume

38

1 reference

23 August 2017

issue

3

1 reference

23 August 2017

page(s)

1717-1721

1 reference

Association of STAT4 polymorphism with rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S11033-010-0285-X

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-010-0285-X

The role of interleukin-1 in the pathogenesis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-010-0285-X

Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-010-0285-X

Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-010-0285-X

Interleukin-17 and type 17 helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-010-0285-X

Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-010-0285-X

Interleukin-21 as a new therapeutic target for immune-mediated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-010-0285-X

Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-010-0285-X

A positive feedback loop of IL-21 signaling provoked by homeostatic CD4 CD25- T cell expansion is essential for the development of arthritis in autoimmune K/BxN mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-010-0285-X

The Yin and Yang of interleukin-21 in allergy, autoimmunity and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-010-0285-X

IL-21 administration into the nostril alleviates murine allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-010-0285-X

Interleukin 21 as a target of intervention in autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-010-0285-X

Interleukin-21 inhibits dendritic cell activation and maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-010-0285-X

Identification of the earliest prethymic bipotent T/NK progenitor in murine fetal liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-010-0285-X

IL-21 is highly produced in Helicobacter pylori-infected gastric mucosa and promotes gelatinases synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-010-0285-X

Biology of IL-21 and the IL-21 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-010-0285-X

IL-21 and IL-21 Receptor: A New Cytokine Pathway Modulates Innate and Adaptive Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-010-0285-X

Transcriptional activation of the interleukin-21 gene and its receptor gene by human T-cell leukemia virus type 1 Tax in human T-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-010-0285-X

IL-21: a novel IL-2-family lymphokine that modulates B, T, and natural killer cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-010-0285-X

Interleukin-21: a new modulator of immunity, infection, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-010-0285-X

Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-010-0285-X

IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-010-0285-X

Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-010-0285-X

Interleukin-21 induces T-cell activation and proinflammatory cytokine secretion in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-010-0285-X

Interleukin-21 signaling: functions in cancer and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-010-0285-X

Targeting IL-17 and Th17 cells in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-010-0285-X

The role of interleukin-17 in mediating joint destruction in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-010-0285-X

Neutralizing IL-21 and IL-15 inhibits pro-inflammatory cytokine production in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-010-0285-X

The common gamma chain (gamma c) is a required signaling component of the IL-21 receptor and supports IL-21-induced cell proliferation via JAK3

21 January 2018

2 references

https://api.crossref.org/works/10.1007/S11033-010-0285-X

21 January 2018

12 December 2020

IL-21 regulates Th17 cells in rheumatoid arthritis

1 reference

12 December 2020

Interleukin-21 and the IL-21 receptor: novel effectors of NK and T cell responses

1 reference

12 December 2020

Interleukin-21: biology and application to cancer therapy

1 reference

12 December 2020

Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis

1 reference

12 December 2020

Identifiers

DOI

1 reference

23 August 2017

1 reference